Investigating the Role of Oncotype DX in the Treatment of Early Stage Luminal A Breast

被引：0
作者：
Hughes, L. [1 ]
Mcveigh, T. [1 ]
Keane, M. [2 ]
Sweeney, K. [1 ]
Kerin, M. [1 ]
机构：
[1] Natl Univ Ireland Galway, Discipline Surg, Galway, Ireland
[2] Galway Univ Hosp, Dept Oncol, Galway, Ireland
来源：
BRITISH JOURNAL OF SURGERY | 2015年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1033
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [41] Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
    Caitlin Taylor
    Jane Meisel
    Aimee J. Foreman
    Christy Russell
    Dipankar Bandyopadhyay
    Xiaoyan Deng
    Lisa Floyd
    Amelia Zelnak
    Harry Bear
    Ruth O’Regan
    Breast Cancer Research and Treatment, 2023, 199 : 91 - 98
  • [42] Direct comparison of risk classification between MammaPrint®, Oncotype DX® and MammoStrat® assays in patients with early stage breast cancer
    Shivers, S. C.
    Clark, L.
    Esposito, N.
    Howard, N.
    King, J.
    Acs, G.
    Ellis, D.
    Vrcelj, V.
    Zanchi, A.
    Stork-Sloots, L.
    de Snoo, F.
    Baehner, F. L.
    Butler, S. M.
    Jamshadian, F.
    Sing, A. P.
    Blumencranz, P. W.
    Cox, C. E.
    CANCER RESEARCH, 2013, 73
  • [43] Comparison of PREDICT Score to Oncotype Dx Score in Early Invasive Breast Cancer
    Frixou, M.
    Makaranka, S.
    Urquhart, G.
    Elsberger, B.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [44] Evaluation of Oncotype DX testing and subsequent patterns of care in patients (pts) with early-stage breast cancer (ESBC).
    Fitzgerald, Meghan
    Hassell, Robert
    Haislip, Sally
    Gilmore, James W.
    Richardson, Steve
    Cooper, Joseph
    Szabo, Stephen
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer
    Boer, Katalin
    Kaposi, Ambrus
    Kocsis, Judit
    Horvath, Zsolt
    Madaras, Balazs
    Savolt, Akos
    Klement, Gyorgy Benjamin
    Rubovszky, Gabor
    CANCERS, 2024, 16 (17)
  • [46] Use of Oncotype DX in Bilateral Breast Cancer
    Li, Pamela
    Cate, Sarah
    Malamud, Stephen
    Chadha, Manjeet
    Gillego, Alyssa
    Boolbol, Susan
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 74 - 75
  • [47] Is Oncotype DX necessary in Mucinous Breast Carcinoma?
    Chang, Allison
    Singh, Kamaljeet
    Wang, Li Juan
    Yakirevich, Evgeny
    Witherby, Sabrina
    Wang, Yihong
    LABORATORY INVESTIGATION, 2024, 104 (03) : S130 - S130
  • [48] Selection of neoadjuvant treatment based on oncotype score in luminal breast cancer
    Gasol Cudos, A.
    Morales Murillo, S.
    Veas Rodriguez, J.
    Canosa Morales, C.
    Mele Olive, J.
    Vilardell Villellas, F.
    Sanchez Guzman, D. R.
    Iglesias Martinez, E.
    Salud Salvia, A.
    BREAST, 2019, 44 : S72 - S72
  • [49] Oncotype Dx in Men with Invasive Breast Cancer
    Duckworth, Lauren
    Hoda, Raza
    Komforti, Miglena
    Lewis, Gloria
    Cui, Xiaoyan
    Silbiger, Daniel
    Rowe, J. Jordi
    Downs-Kelly, Erinn
    McIntire, Patrick
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 111 - 112
  • [50] Genomic signature in breast cancer: Oncotype DX®
    Teig, Benjamin
    ANNALES DE PATHOLOGIE, 2013, 33 (03) : 225 - 228
12345